Human immune systems were ill-prepared for the swine flu virus that spread across the globe in 2009. The lack of pre-existing immunity left people vulnerable but, researchers wondered, was everyone equally unprotected? Answering this question has led to a 'blueprint' for a universal flu vaccine.
Evidence linking GlaxoSmithKline's swine flu vaccine to narcolepsy has mounted up this year, with new findings from Finland, Sweden and the United Kingdom emerging. Now, having previously knocked back compensation claims, the data has prompted the U.K. government to accept the link.
From 2009 to 2011, 25 adults developed narcolepsy in Finland, 18 of whom had received GSK's swine flu vaccine, Pandemrix.
The Swedish regulator has added to evidence linking GlaxoSmithKline's swine flu vaccine to narcolepsy in a registry study of 5.8 million people.
Research linking GlaxoSmithKline's ($GSK) swine flu vaccine to narcolepsy has precipitated calls for a rereview of a similar product before FDA makes an approval decision.
Swine flu has infected 113 people in Indiana, and that number is on the rise.
The U.S. Centers for Disease Control isn't taking any chances when it comes to swine flu. A new strain of the flu--H3N2--includes an element seen in the H1N1 swine flu pandemic of 2009, so the CDC is preparing a candidate vaccine and clinical trials for later this year.
Most women are careful about what drugs they take or what treatments they have while they are pregnant, but the H1N1 swine flu shot given during pregnancy seems to have an added bonus: a lower risk of stillbirths or premature births, and a lower number of very small babies born.
Researchers in Canada are touting a 2009 swine flu shot as a potential route to a universal vaccine that could target all forms of influenza, according to data published in Frontiers of Immunology.
About 2 of every 3 American adults aged 36 to 39 tracked the frenzy of reports that erupted after the swine flu pandemic broke out and concluded that there was something there that was at least...